ES8103055A1 - Un procedimiento para la preparacion de un imidazol susti- tuido en la posicion 1 - Google Patents

Un procedimiento para la preparacion de un imidazol susti- tuido en la posicion 1

Info

Publication number
ES8103055A1
ES8103055A1 ES488803A ES488803A ES8103055A1 ES 8103055 A1 ES8103055 A1 ES 8103055A1 ES 488803 A ES488803 A ES 488803A ES 488803 A ES488803 A ES 488803A ES 8103055 A1 ES8103055 A1 ES 8103055A1
Authority
ES
Spain
Prior art keywords
heteroatoms
unsaturated
saturated
sulphur
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488803A
Other languages
English (en)
Other versions
ES488803A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES488803A0 publication Critical patent/ES488803A0/es
Publication of ES8103055A1 publication Critical patent/ES8103055A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UN IMIDAZOL SUSTITUIDO EN LA POSICION 1, EN UNA SAL DE ADICION DEL MISMO O DE UN BIOPRECURSOR FARMACEUTICAMENTE ACEPTABLE DE DICHO IMIDAZOL. LA FORMULA GENERAL DEL IMIDAZOL A OBTENER ES LA SIGUIENTE (I), DONDE. A ES UN ENLACE QUIMICO O UN RESIDUO ALIFATICO OPCIONALMENTE SUSTITUIDO Y R ES UN SISTEMA CICLICO NO AROMATICO QUE CUMPLE UNAS CIERTAS CONDICIONES. EL PROCEDIMIENTO SE FUNDAMENTA EN LA REACCION DEL IMIDAZOL O DE UNA SE SUS SALES CON UN AGENTE DE FORMULA: Z-A-R DONDE A Y R TIENEN EL SIGNIFICADO ANTERIORMENTE INDICADO Y Z ES UN GRUPO ELIMINABLE. DICHA REACCION SE LLEVA A CABO, EN ALGUNOS CASOS, EN PRESENCIA DE UN ACEPTOR DE ACIDO O DE UN AGENTE DE DESHIDRATACION. ESTOS COMPUESTOS SON DE EMPLEO EN EL TRATAMIENTO DE ENFERMEDADES TROBOEMBOLICAS EN MAMIFEROS Y EN EL HOMBRE. *FORMULA*.
ES488803A 1979-02-22 1980-02-21 Un procedimiento para la preparacion de un imidazol susti- tuido en la posicion 1 Expired ES8103055A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7906243 1979-02-22

Publications (2)

Publication Number Publication Date
ES488803A0 ES488803A0 (es) 1981-02-16
ES8103055A1 true ES8103055A1 (es) 1981-02-16

Family

ID=10503360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488803A Expired ES8103055A1 (es) 1979-02-22 1980-02-21 Un procedimiento para la preparacion de un imidazol susti- tuido en la posicion 1

Country Status (20)

Country Link
US (2) US4328234A (es)
EP (1) EP0015002B1 (es)
JP (1) JPS55115872A (es)
KR (1) KR850000380B1 (es)
AT (1) AT373881B (es)
AU (1) AU531899B2 (es)
DE (1) DE3067505D1 (es)
DK (1) DK75680A (es)
ES (1) ES8103055A1 (es)
FI (1) FI800519A (es)
GB (1) GB2044259B (es)
GR (1) GR70277B (es)
HU (1) HU188123B (es)
IE (1) IE49744B1 (es)
IL (1) IL59444A0 (es)
IT (1) IT1128095B (es)
MC (1) MC1315A1 (es)
NZ (1) NZ192941A (es)
PT (1) PT70856B (es)
ZA (1) ZA80996B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT70856B (en) * 1979-02-22 1981-06-11 Wellcome Found Imidazole derivatives and salts thereof their synthesis and pharmaceutical formulations
DE2944663A1 (de) * 1979-11-06 1981-05-14 Bayer Ag, 5090 Leverkusen Imidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2944662A1 (de) * 1979-11-06 1981-05-14 Bayer Ag, 5090 Leverkusen Cycloheptatrienylimidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS6036427B2 (ja) * 1980-12-05 1985-08-20 塩野義製薬株式会社 １−ベンジルイミダゾ−ル誘導体
ATE29494T1 (de) * 1983-08-11 1987-09-15 Synthelabo Indol-derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
DE3508905A1 (de) * 1985-03-13 1986-09-18 Hoechst Ag, 6230 Frankfurt Neue imidazolylverbindungen und verfahren zu ihrer herstellung
US4783474A (en) * 1985-07-20 1988-11-08 Bayer Aktiengesellschaft Halogenoalkyl-, alkenyl- and alkinyl-azoles
DE3700916A1 (de) * 1987-01-14 1988-07-28 Bayer Ag Halogenalkyl-, alkenyl- und alkinyl-azole
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
DE3827117A1 (de) * 1988-08-10 1990-02-15 Ruetgerswerke Ag Verfahren zur herstellung von chinuclidin-3-methanol
IT1251431B (it) * 1991-10-25 1995-05-09 Costante Fontana Composto ad elevate caratteristiche stabilizzanti particolarmente per perossidi inorganici utilizzati in applicazioni industriali
DE69637097T2 (de) * 1995-10-13 2007-09-20 Neurosearch A/S 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung
MX2007012091A (es) * 2005-03-31 2007-11-20 Schering Corp Antagonistas espirociclicos de los receptores de trombina.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29935A (en) * 1860-09-04 Joseph f
US2836598A (en) * 1958-05-27 Tertiary-amino - substituted i
US3259637A (en) * 1963-05-27 1966-07-05 Frosst & Co Charles E 3, 3-dimethyl-8-bromomethyl-2, 7-dioxaspiro (4.4)nonane
GB1164564A (en) 1967-08-21 1969-09-17 Shell Int Research Novel Cyclobexylpentadienone Acid Derivatives, the preparation thereof and Compositions containing the same
USRE29935E (en) * 1968-11-29 1979-03-13 Bayer Aktiengesellschaft N-Substituted imidazoles and their salts
DE2007794A1 (de) * 1970-02-20 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Fungizide Mittel
US3666755A (en) * 1970-03-26 1972-05-30 Merck & Co Inc 2-imidazolylbicyclo{8 2.2.2{9 octanes
DE2016839C3 (de) * 1970-04-09 1979-03-22 Bayer Ag, 5090 Leverkusen PhenyM4-phenoxyphenyi)-imidazol-1-yl-methane, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US3682951A (en) * 1970-11-02 1972-08-08 Searle & Co 1-{8 {62 -(1-adamantyloxy)halophenethyl{9 {0 imidazoles and congeners
FR2129838A1 (en) * 1971-03-16 1972-11-03 Boehringer Mannheim Gmbh Diuretic/saluretic dibenzo cycloheptene - derivs
US4107206A (en) * 1974-04-08 1978-08-15 Akzona Incorporated Benzo-bicyclononene- derivatives
SE7600674L (sv) * 1975-02-05 1976-08-06 Rohm & Haas Fungicider
US4057549A (en) * 1975-04-16 1977-11-08 G. D. Searle & Co. Triarylpropyl-azabicyclooctanes
US4156694A (en) * 1975-04-29 1979-05-29 Akzona Incorporated Benzobicyclononene derivatives
US4036975A (en) * 1975-07-28 1977-07-19 Xyntex (U.S.A) Inc. 1-[2-(1-Adamantyl)-2-(R-thio)ethyl]imidazoles and 1-[2-(1-adamantyl)-2-(R-oxy)ethyl]imidazoles
US4031224A (en) * 1976-04-29 1977-06-21 American Hoechst Corporation 1,3-Dihydro-heteroarylspiro (isobenzofuran)s
US4396771A (en) * 1977-10-19 1983-08-02 Burroughs Wellcome Co. Imidazole derivatives and salts thereof
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
PT70856B (en) * 1979-02-22 1981-06-11 Wellcome Found Imidazole derivatives and salts thereof their synthesis and pharmaceutical formulations

Also Published As

Publication number Publication date
AT373881B (de) 1984-02-27
DK75680A (da) 1980-08-23
KR850000380B1 (ko) 1985-03-23
EP0015002A1 (en) 1980-09-03
AU531899B2 (en) 1983-09-08
ATA97580A (de) 1983-07-15
EP0015002B1 (en) 1984-04-18
GB2044259B (en) 1983-08-03
IE49744B1 (en) 1985-12-11
IL59444A0 (en) 1980-05-30
IE800341L (en) 1980-08-22
KR830001904A (ko) 1983-05-19
JPS55115872A (en) 1980-09-06
IT8047968A0 (it) 1980-02-21
DE3067505D1 (en) 1984-05-24
ES488803A0 (es) 1981-02-16
ZA80996B (en) 1981-04-29
US4328234A (en) 1982-05-04
AU5576580A (en) 1980-08-28
IT1128095B (it) 1986-05-28
GR70277B (es) 1982-09-03
NZ192941A (en) 1984-10-19
PT70856B (en) 1981-06-11
US4525475A (en) 1985-06-25
HU188123B (en) 1986-03-28
FI800519A (fi) 1980-08-23
GB2044259A (en) 1980-10-15
MC1315A1 (fr) 1981-03-10
PT70856A (en) 1980-03-01

Similar Documents

Publication Publication Date Title
CS195285A3 (en) Pyridazine derivatives substituted by cyclic amines and process forpreparing thereof
ES8103055A1 (es) Un procedimiento para la preparacion de un imidazol susti- tuido en la posicion 1
AU5791190A (en) New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
DK163144C (da) Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf
ZA839615B (en) Dialkyl-amino-alkoxy derivatives,process for their preparation and pharmaceutical compositions containing them
SE7608203L (sv) Forfarande for framstellning av substituerade difenylsulfider
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES8304087A1 (es) &#34;un metodo de preparar derivados de pirazolina&#34;.
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
ES8401088A1 (es) Un procedimiento para la produccion de derivados de fosforamida.
ES8308562A1 (es) Procedimiento para preparar 3&#39;,4&#39;,5&#39;-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
ES8403482A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
FR2357551A1 (fr) Nouvelles 2,5-dideoxystreptamines et leur procede de preparation
ES8502689A1 (es) Procedimiento para la preparacion de derivados de benzazepina.
DE3065093D1 (en) Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation
DE3367209D1 (en) Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them
ATE23528T1 (de) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidine, pharmazeutische zusammenstellungen die sie enthalten, verfahren zur herstellung und deren zwischenprodukte.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
ES8600768A1 (es) Imidazotiadiazolalquencarboxiamidas
ES478073A1 (es) Un procedimiento de preparacion de benzamidas.
PT71895B (en) Process for the preparation of nb-quaternary 10-bromosanduicine and 10-bromoisanduicine derivatives
PH15938A (en) Nb-quaternary derivatives of ajmaline and isoajmaline,process for their preparation and composition containing them